Wei‐Ying Jen

Assessing the Impact of a Pulmonary Embolism Response Team and Treatment Protocol on Patients Presenting With Acute Pulmonary Embolism

Wei‐Ying Jen, William Kristanto, Lynette Teo et al. · Heart Lung and Circulation · 2019 · 43 citations

Medicine, Clinical Sciences, Internal Medicine +14

Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia

Courtney D. DiNardo, Wei‐Ying Jen, Koichi Takahashi et al. · Leukemia · 2025 · 35 citations · Full text

Medicine, Hematology, Oncology +16

Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy–Ineligible Patients With Isocitrate Dehydrogenase–Mutated AML

Courtney D. DiNardo, Jennifer Marvin‐Peek, Sanam Loghavi et al. · Journal of Clinical Oncology · 2025 · 21 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

FLAG-IDA + venetoclax in newly diagnosed (ND) or relapsed/refractory (RR) AML.

Wei‐Ying Jen, Koichi Takahashi, Sanam Loghavi et al. · Journal of Clinical Oncology · 2024 · 18 citations

Medicine, Oncology, Pharmacology +15

<p>Qualitative Study of Factors Affecting Patient, Caregiver and Physician Preferences for Treatment of Myeloma and Indolent Lymphoma</p>

Wei‐Ying Jen, Joanne Yoong, Xin Liu et al. · Patient Preference and Adherence · 2020 · 17 citations · Full text

Medicine, Oncology, Hematologic Oncology +16